Synthomer raised its 2026 guidance following 13% EBITDA growth and margin expansion to 10.1% in the first half.
Synthomer reported first-half revenue of £954 million, up 6.7% year-on-year, driven by specialty products and cost efficiencies. EBITDA rose 13% to £96.4 million, with margins expanding 80 basis points to 10.1%. Volumes increased 2.3% across the group.
The company raised its full-year outlook, forecasting covenant leverage of 4.0–4.35 times by year-end, down from 4.9 times at June 30. Free cash flow is expected to turn positive, supported by £150 million–£200 million from planned disposals. CCS and Adhesive Solutions led growth despite operational disruptions.
Shares reacted modestly as investors digested the improved guidance and margin performance. The company highlighted ongoing portfolio reshaping and operational improvements as key priorities.